1Mancia G, Zanchetti A, Agabiti-Rosei E, et al . Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertophy[J]. Hypertension, 1990,4(3) :324-328.
2Goodfriend T,Elliott M E, Catt J. Angiotensin receptors and their antagonists[J]. N Engl J Med, 1996, 334(6): 1649-1654.
3Koren M J, Devereuz R B, Casale P N, et al . Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension[J]. Ann Intern Med,2001,114(3) : 345-352.
4Opanrias B, Elkins M. Tolerability and effects on quality of losartan, alone or with hydochlorothiazide[J]. Hypertension,1996,18(5):608-625.
5Malmqvist K, Kahan T, Edner M, et al. Regression of left ventricular hypertrophy in human hypertension with irbesartan[J]. Hypertension, 2001,19(M6) : 1167-1176.
6Martina B, Dieterle T, Weinbacher M, et al. Effects of losartan titrated to losartan/hydrochlorot hiazide and amlodipine on left ventricular mass in patients with mild-to-moderate hypertension-a double-blind randomized controlled study[J]. Cardiology, 1999, 92(1): 110-114.
7Crozer I, Ikram H, Awan N. Losartan in heart failure Hemodynanie effects and tolerability[J]. Circulation 1995,91(6) :691-709.
8Tedeseo M A, Ratti G, Aquino D, et al. Effects of losartan on hypertension and left ventricular mass: a long-term study[J]. Hypertension, 1998, 12(4) : 505-510.
9Thurmann P A, Kenedi P, Schmidt A, et al. Influence of the angiotensin II antagonist valsartan on left ventricular hypertrophy in patients with essential hypertension [J].Circulation, 1998, 98(9): 2037-2042.
10Karakoc A, Arinsoy T, Gencosmanoglu O, et al . Effects of an angiotensin Ⅱ receptor antagonist on urinary albumin excretion, left ventricular mass, and systolic and diastolic blood pressures in essential hypertension[J]. Clinical foucus,1999, 60(2): 295-303.
